Revvity Inc. (NYSE:RVTY) Receives Average Recommendation of “Hold” from Brokerages

Revvity Inc. (NYSE:RVTY) has received a consensus rating of “Hold” from the fifteen ratings firms that are covering the firm, Marketbeat Ratings reports. Twelve equities research analysts have rated the stock with a hold rating and three have issued a buy rating on the company. The average 12-month target price among brokerages that have updated their coverage on the stock in the last year is $108.3636.

A number of analysts have recently commented on RVTY shares. Barclays boosted their price target on Revvity from $95.00 to $105.00 and gave the stock an “equal weight” rating in a research report on Thursday, May 7th. Sanford C. Bernstein assumed coverage on Revvity in a research note on Friday, June 26th. They set a “market perform” rating and a $115.00 price objective for the company. Wolfe Research began coverage on Revvity in a report on Tuesday, June 2nd. They issued a “peer perform” rating on the stock. TD Cowen reissued a “buy” rating on shares of Revvity in a research note on Wednesday, July 15th. Finally, JPMorgan Chase & Co. reduced their price target on Revvity from $96.00 to $90.00 and set a “neutral” rating for the company in a report on Wednesday, May 6th.

Revvity Trading Down 0.4%

NYSE:RVTY opened at $116.36 on Thursday. Revvity has a one year low of $81.22 and a one year high of $118.34. The company has a debt-to-equity ratio of 0.36, a current ratio of 1.80 and a quick ratio of 1.50. The company’s 50-day simple moving average is $109.93 and its 200 day simple moving average is $100.00. The firm has a market capitalization of $12.98 billion, a P/E ratio of 55.41, a PEG ratio of 2.13 and a beta of 1.07.

Revvity (NYSE:RVTY) last announced its earnings results on Tuesday, August 4th. The company reported $1.41 earnings per share for the quarter, beating analysts’ consensus estimates of $1.21 by $0.20. Revvity had a net margin of 8.16% and a return on equity of 8.34%. The business had revenue of $729.69 million during the quarter, compared to the consensus estimate of $702.96 million. During the same quarter last year, the firm earned $1.18 earnings per share. The business’s revenue for the quarter was down 1.3% on a year-over-year basis. Revvity has set its FY 2026 guidance at 5.300-5.400 EPS. As a group, analysts forecast that Revvity will post 5.36 EPS for the current fiscal year.

Revvity Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, November 13th. Investors of record on Friday, October 23rd will be paid a $0.07 dividend. The ex-dividend date is Friday, October 23rd. This represents a $0.28 dividend on an annualized basis and a yield of 0.2%. Revvity’s payout ratio is presently 13.33%.

Institutional Trading of Revvity

Institutional investors and hedge funds have recently bought and sold shares of the company. New Mexico Educational Retirement Board lifted its stake in shares of Revvity by 1.9% in the fourth quarter. New Mexico Educational Retirement Board now owns 5,416 shares of the company’s stock worth $524,000 after buying an additional 100 shares in the last quarter. Allworth Financial LP increased its position in shares of Revvity by 8.9% during the fourth quarter. Allworth Financial LP now owns 1,275 shares of the company’s stock valued at $123,000 after acquiring an additional 104 shares in the last quarter. EverSource Wealth Advisors LLC increased its position in shares of Revvity by 17.0% during the first quarter. EverSource Wealth Advisors LLC now owns 749 shares of the company’s stock valued at $66,000 after acquiring an additional 109 shares in the last quarter. HighTower Advisors LLC raised its holdings in Revvity by 2.6% in the 4th quarter. HighTower Advisors LLC now owns 5,141 shares of the company’s stock worth $497,000 after acquiring an additional 129 shares during the last quarter. Finally, Cary Street Partners Financial LLC raised its holdings in Revvity by 1.6% in the 4th quarter. Cary Street Partners Financial LLC now owns 8,941 shares of the company’s stock worth $865,000 after acquiring an additional 141 shares during the last quarter. 86.65% of the stock is currently owned by institutional investors.

About Revvity

Revvity, Inc is a global provider of technology-enabled solutions for the life sciences, diagnostics and applied markets. The company develops and supplies a range of products and services, including reagents and consumables, laboratory instruments, workflow automation, software analytics and technical support. Its portfolio supports applications in drug discovery, genomics, cell biology research, environmental and food safety testing, industrial quality control and clinical diagnostics.

Tracing its heritage to Perkin-Elmer, founded in 1937, Revvity began trading on the New York Stock Exchange under the ticker symbol RVTY in January 2024 following a corporate rebranding.